Literature DB >> 24813230

Ovarian tumor-associated microRNA-20a decreases natural killer cell cytotoxicity by downregulating MICA/B expression.

Jingyan Xie1, Mengna Liu1, Yujuan Li1, Yunzhong Nie2, Qiongyu Mi1, Shuli Zhao3.   

Abstract

MicroRNAs (miRNAs) are a class of small non-coding regulatory RNAs, and changes in miRNAs are involved in tumor origin and progression. Studies have shown that miR-20a is overexpressed in human ovarian cancer tissues and that this miRNA enhances long-term cellular proliferation and invasion capabilities. In this study, a positive correlation between serum miR-20a expression and ovarian cancer stage was observed. We found that miR-20a binds directly to the 3'-untranslated region of MICA/B mRNA, resulting in its degradation and reducing its protein levels on the plasma membrane. Reduction of membrane-bound MICA/B proteins, which are ligands of the natural killer group 2 member D (NKG2D) receptor found on natural killer (NK) cells, γδ(+) T cells and CD8(+) T cells, allows tumor cells to evade immune-mediated killing. Notably, antagonizing miR-20a action enhanced the NKG2D-mediated killing of tumor cells in both in vitro and in vivo models of tumors. Taken together, our data indicate that increased levels of miR-20a in tumor cells may indirectly suppress NK cell cytotoxicity by downregulating MICA/B expression. These data provide a potential link between metastasis capability and immune escape of tumor cells from NK cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24813230      PMCID: PMC4197204          DOI: 10.1038/cmi.2014.30

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  31 in total

1.  Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation.

Authors:  Eric C Lai
Journal:  Nat Genet       Date:  2002-03-18       Impact factor: 38.330

2.  miR-20a promotes proliferation and invasion by targeting APP in human ovarian cancer cells.

Authors:  Xingxing Fan; Yankun Liu; Jiechun Jiang; Zhuoya Ma; Haidong Wu; Tao Liu; Min Liu; Xin Li; Hua Tang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2010-05-15       Impact factor: 3.848

Review 3.  Effect of NKG2D ligand expression on host immune responses.

Authors:  Marine Champsaur; Lewis L Lanier
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

4.  miR-214 regulates lactoferrin expression and pro-apoptotic function in mammary epithelial cells.

Authors:  Yalin Liao; Xiaogu Du; Bo Lönnerdal
Journal:  J Nutr       Date:  2010-07-07       Impact factor: 4.798

5.  Circulating microRNAs as stable blood-based markers for cancer detection.

Authors:  Patrick S Mitchell; Rachael K Parkin; Evan M Kroh; Brian R Fritz; Stacia K Wyman; Era L Pogosova-Agadjanyan; Amelia Peterson; Jennifer Noteboom; Kathy C O'Briant; April Allen; Daniel W Lin; Nicole Urban; Charles W Drescher; Beatrice S Knudsen; Derek L Stirewalt; Robert Gentleman; Robert L Vessella; Peter S Nelson; Daniel B Martin; Muneesh Tewari
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-28       Impact factor: 11.205

6.  Export of microRNAs and microRNA-protective protein by mammalian cells.

Authors:  Kai Wang; Shile Zhang; Jessica Weber; David Baxter; David J Galas
Journal:  Nucleic Acids Res       Date:  2010-07-07       Impact factor: 16.971

7.  Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases.

Authors:  Xi Chen; Yi Ba; Lijia Ma; Xing Cai; Yuan Yin; Kehui Wang; Jigang Guo; Yujing Zhang; Jiangning Chen; Xing Guo; Qibin Li; Xiaoying Li; Wenjing Wang; Yan Zhang; Jin Wang; Xueyuan Jiang; Yang Xiang; Chen Xu; Pingping Zheng; Juanbin Zhang; Ruiqiang Li; Hongjie Zhang; Xiaobin Shang; Ting Gong; Guang Ning; Jun Wang; Ke Zen; Junfeng Zhang; Chen-Yu Zhang
Journal:  Cell Res       Date:  2008-10       Impact factor: 25.617

8.  Propionic acid secreted from propionibacteria induces NKG2D ligand expression on human-activated T lymphocytes and cancer cells.

Authors:  Lars Andresen; Karen Aagaard Hansen; Helle Jensen; Stine Falsig Pedersen; Peter Stougaard; Helle Rüsz Hansen; Jesper Jurlander; Søren Skov
Journal:  J Immunol       Date:  2009-06-24       Impact factor: 5.422

9.  MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood.

Authors:  Mathew B Cox; Murray J Cairns; Kaushal S Gandhi; Adam P Carroll; Sophia Moscovis; Graeme J Stewart; Simon Broadley; Rodney J Scott; David R Booth; Jeannette Lechner-Scott
Journal:  PLoS One       Date:  2010-08-11       Impact factor: 3.240

10.  Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries.

Authors:  Stacia K Wyman; Rachael K Parkin; Patrick S Mitchell; Brian R Fritz; Kathy O'Briant; Andrew K Godwin; Nicole Urban; Charles W Drescher; Beatrice S Knudsen; Muneesh Tewari
Journal:  PLoS One       Date:  2009-04-23       Impact factor: 3.240

View more
  40 in total

Review 1.  Epigenetic Mechanisms Dictating Eradication of Cancer by Natural Killer Cells.

Authors:  Suresh Bugide; Radoslav Janostiak; Narendra Wajapeyee
Journal:  Trends Cancer       Date:  2018-07-03

Review 2.  Role of NKG2D and its ligands in cancer immunotherapy.

Authors:  Huifang Liu; Sijia Wang; Jing Xin; Jing Wang; Cuiping Yao; Zhenxi Zhang
Journal:  Am J Cancer Res       Date:  2019-10-01       Impact factor: 6.166

3.  microRNA-889 is downregulated by histone deacetylase inhibitors and confers resistance to natural killer cytotoxicity in hepatocellular carcinoma cells.

Authors:  Haitao Xie; Qiugui Zhang; Hui Zhou; Jun Zhou; Ji Zhang; Yan Jiang; Jinghong Wang; Xianglin Meng; Leping Zeng; Xiaoxin Jiang
Journal:  Cytotechnology       Date:  2017-05-26       Impact factor: 2.058

Review 4.  Tissue-Resident Innate Immune Cell-Based Therapy: A Cornerstone of Immunotherapy Strategies for Cancer Treatment.

Authors:  Rosalia Busà; Matteo Bulati; Ester Badami; Giovanni Zito; Daniela Claudia Maresca; Pier Giulio Conaldi; Giuseppe Ercolano; Angela Ianaro
Journal:  Front Cell Dev Biol       Date:  2022-05-26

5.  Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.

Authors:  Fu-Cheng He; Wei-Wei Meng; Yun-Hui Qu; Ming-Xia Zhou; Jing He; Pin Lv; Liang Ming
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

6.  Down-regulation of UL16-binding protein 3 mediated by interferon-gamma impairs immune killing in nasopharyngeal carcinoma.

Authors:  Lingling Guo; Yu Chen; Jing Wang; Chuanben Chen
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

Review 7.  MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma.

Authors:  Xiang Li; Jing Nie; Qian Mei; Wei-Dong Han
Journal:  World J Gastroenterol       Date:  2016-06-21       Impact factor: 5.742

Review 8.  Cancer-derived exosomic microRNAs shape the immune system within the tumor microenvironment: State of the art.

Authors:  Francesca Fanini; Muller Fabbri
Journal:  Semin Cell Dev Biol       Date:  2016-12-09       Impact factor: 7.727

Review 9.  Tumor Immune Microenvironment and Its Related miRNAs in Tumor Progression.

Authors:  Yingying Xing; Guojing Ruan; Haiwei Ni; Hai Qin; Simiao Chen; Xinyue Gu; Jiamin Shang; Yantong Zhou; Xi Tao; Lufeng Zheng
Journal:  Front Immunol       Date:  2021-05-18       Impact factor: 7.561

10.  Immune-Related Nine-MicroRNA Signature for Predicting the Prognosis of Gastric Cancer.

Authors:  Jingxuan Xu; Jian Wen; Shuangquan Li; Xian Shen; Tao You; Yingpeng Huang; Chongyong Xu; Yaping Zhao
Journal:  Front Genet       Date:  2021-07-05       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.